Definitive Healthcare Stock Price, News & Analysis (NASDAQ:DH)

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Definitive Healthcare in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" DH shares.
View DH analyst ratings or view top-rated stocks.

8 equities research analysts have issued twelve-month target prices for Definitive Healthcare's stock. Their DH share price targets range from $9.50 to $15.00. On average, they anticipate the company's share price to reach $11.94 in the next year. This suggests a possible upside of 37.8% from the stock's current price.
View analysts price targets for DH or view top-rated stocks among Wall Street analysts.

Definitive Healthcare's stock was trading at $10.99 at the start of the year. Since then, DH shares have decreased by 21.2% and is now trading at $8.66.
View the best growth stocks for 2023 here.

Definitive Healthcare saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 6,370,000 shares, an increase of 25.6% from the October 31st total of 5,070,000 shares. Based on an average daily volume of 840,700 shares, the days-to-cover ratio is presently 7.6 days. Currently, 13.8% of the company's shares are sold short.
View Definitive Healthcare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 22nd 2024.
View our DH earnings forecast.

Definitive Healthcare Corp. (NASDAQ:DH) issued its earnings results on Thursday, November, 2nd. The company reported $0.01 EPS for the quarter, missing the consensus estimate of $0.02 by $0.01. The business had revenue of $65.33 million for the quarter, compared to analysts' expectations of $63.60 million. Definitive Healthcare had a positive trailing twelve-month return on equity of 0.50% and a negative net margin of 73.75%.

ETFs with the largest weight of Definitive Healthcare (NASDAQ:DH) stock in their portfolio include Alger Weatherbie Enduring Growth ETF (AWEG), Fidelity Digital Health ETF (FDHT) and Global X Telemedicine & Digital Health ETF (EDOC).First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).

Definitive Healthcare issued an update on its fourth quarter earnings guidance on Thursday, November, 2nd. The company provided EPS guidance of $0.06-0.08 for the period, compared to the consensus estimate of $0.03. The company issued revenue guidance of $65.5-66.5 million, compared to the consensus revenue estimate of $66.90 million.

(DH) raised $350 million in an initial public offering on Wednesday, September 15th 2021. The company issued 15,555,555 shares at $21.00-$24.00 per share.

Definitive Healthcare's stock is owned by a number of retail and institutional investors. Top institutional shareholders include JPMorgan Chase & Co. (4.36%), Conestoga Capital Advisors LLC (4.35%), Brown Advisory Inc. (3.50%), Riverbridge Partners LLC (2.30%), Fred Alger Management LLC (2.20%) and Clearbridge Investments LLC (1.94%). Insiders that own company stock include David Randall Winn, Jeffrey Charles Haywood, Richard Douglas Booth and Sea Vii Management, Llc.
View institutional ownership trends.

Shares of DH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.